Stratos Genomics News
Stratos Genomics Inc today announced that it has reached its next significant milestone by achieving single molecule DNA sequencing of 100+ base templates with its patented “Sequencing by Expansion™” (SBX) technology. Stratos Genomics also announced the addition of Tim Hunkapiller, co-inventor of four-color Sanger sequencing, to its Science Advisory Board (SAB).
Stratos Genomics Inc today announced the closing of $2 million to support continued development and strategic discussions related to Stratos’ ultra low cost method of DNA sequencing called “Sequencing by Expansion™” (SBX™).
“The additional funding will allow us to expand our development efforts and bring us one step closer to realizing the enormous potential of our Sequencing by Expansion™ technology.” Mark Kokoris, Chief Science Officer, Stratos Genomics said.
“We are fortunate to have great results and supportive investors. Our shareholders recognize that we are entering an exciting phase and don’t want our validation pace interrupted by external fundraising activities,” CEO Allan Stephan said.
Sequencing by Expansion enables ultra-low-cost sequencing on a range of affordable measurement technologies for servicing a full spectrum of genomic applications.
Stratos Genomics Inc. today announced it has closed a Series-A financing deal of $4 million to continue development of its ultra-low-cost nucleic acid sequencing method for whole genome analysis and molecular diagnostics.
“I believe that Stratos Genomics’ technology has the potential to radically transform the molecular diagnostics industry by, for the first time, performing individual whole genome sequencing at very low costs. It is a privilege to join this exciting and dynamic team, and I look forward to working closely with Al and the board members during the next stages of Stratos Genomics’ growth,” Heiner Dreismann, Ph.D., said.